Greiner Bio-One Licenses Invitrogen's PCR Sample-Prep Tech for HPV Test

Jun 25, 2007

NEW YORK (GenomeWeb News) – Greiner Bio-One has licensed Invitrogen’s deoxyuridine triphosphate technology for use in a PCR-based HPV test and in DNA array products, the companies said today.

Greiner Bio-One said it will use dUTP in place of deoxythymidine triphosphate to prevent false positives during PCR by reducing sample contamination.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

What You Might Learn

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

From Whales to Urchins to Algae

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

In the Skin

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

This Week in PNAS

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.

Main menu